Fibroblast growth factor-23 as a biomarker of adverse outcomes in patients with coronary artery disease: a meta-analysis

Zheng, SZ; Wang, C; Yan, H; Xu, M; Du, YJ

Du, YJ (通讯作者)，Second Peoples Hosp Chengdu, Dept Infect Dis, 10 Qingyun South St, Chengdu 610021, Sichuan, Peoples R China.

BIOMARKERS, 2022; 27 (4): 299

Abstract

Background Fibroblast growth factor-23 (FGF-23) level has been linked the adverse outcomes in patients with coronary artery disease (CAD). The purpose......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索